Dosage Form
Lyophilized Product CDMOs
Compare CDMOs manufacturing lyophilized drug products for biologics, peptides, and injectable pharmaceuticals. Filter by dryer capacity, cycle development expertise, and scale.
128 companies listed
About Lyophilized Product Manufacturing
Lyophilized (freeze-dried) products are manufactured by removing water from a drug formulation through sublimation, producing a stable dry cake that is reconstituted before use. This dosage form is essential for biologics, peptides, and other molecules that are unstable in liquid form. The lyophilization process occurs after aseptic vial filling, making it an integrated part of the sterile manufacturing process.
Key CDMO selection criteria for lyophilized products include: cycle development expertise (thermal analysis, process optimization), dryer capacity (shelf area determines batch size), scale-up capability (lab to commercial dryers), and integrated fill-finish services. CDMOs offering end-to-end fill-lyophilize-inspect services eliminate the logistics complexity of shipping partially stoppered vials between facilities.
Companies (128)
Vetter Pharma
Germany
Vetter Pharma is a leading global Contract Development and Manufacturing Organization specializing in aseptic fill-and-finish services for injectable drug products. Headquartered in Ravensburg, Germany, Vetter operates as an independent, family-owned business with over 75 years of experience.
Biologics Drug ProductFill/Finish (Vials)Fill/Finish (Syringes)
R
ResolveMass Laboratories Inc.
Canada
ResolveMass Laboratories Inc. is a Canadian pharmaceutical CRO and CDMO providing analytical testing, characterization, and drug development support for pharmaceutical, biotechnology, and medical device companies worldwide. Our expertise spans small molecules, peptides, biologics, biosimilars, oligonucleotides, polymers, and complex drug products. We offer specialized services including mass spectrometry (LC-MS/MS, LC-HRMS), peptide characterization, impurity identification, nitrosamine analysis, extractables and leachables (E&L) studies, bioanalytical testing, stability studies, method development, and regulatory support. Our multidisciplinary scientific team helps clients address complex analytical challenges and generate high-quality data to support research, development, manufacturing, and regulatory submissions. ResolveMass Laboratories operates from Canada and serves clients across North America, Europe, and Asia. The company maintains an ISO 9001:2015 certified Quality Management System, is FDA-registered, and holds a Health Canada Drug Establishment Licence for GMP-compliant operations. We are committed to delivering scientifically rigorous, reliable, and timely solutions that accelerate drug development and support regulatory success.
Frequently Asked Questions
What products are typically lyophilized?+
Common lyophilized products include: monoclonal antibodies (when liquid formulation stability is insufficient), vaccines, peptide and protein therapeutics, oligonucleotide drugs, certain antibiotics (e.g., vancomycin), and diagnostic reagents. The decision to lyophilize depends on the product's liquid stability, target shelf life, and cold chain requirements.
What is the typical lyophilization cycle time?+
Cycle times vary significantly by product: simple small molecule formulations may lyophilize in 24-48 hours, while complex biologics can require 72-120 hours. Cycle optimization by an experienced CDMO can reduce these times by 20-40% while maintaining product quality. The total vial processing time (fill through lyophilization through stoppering and crimping) is typically 4-7 days per batch.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
